國立高雄大學圖資館 |

Language: English

Back

Radiopharmaceuticalsa guide to PET/CT and PET/MRI /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Radiopharmaceuticalsedited by Ferdinando Calabria, Orazio Schillaci.
Reminder of title:	a guide to PET/CT and PET/MRI /
other author:	Calabria, Ferdinando.
Published:	Cham :Springer Nature Switzerland :2024.
Description:	x, 330 p. :ill. (chiefly col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Radiopharmaceuticals.
Online resource:	https://doi.org/10.1007/978-3-031-54196-4
ISBN:	9783031541964$q(electronic bk.)

Radiopharmaceuticalsa guide to PET/CT and PET/MRI /
Radiopharmaceuticalsa guide to PET/CT and PET/MRI /[electronic resource] :edited by Ferdinando Calabria, Orazio Schillaci. - Third edition. - Cham :Springer Nature Switzerland :2024. - x, 330 p. :ill. (chiefly col.), digital ;24 cm.

1. 18F-FDG -- 2. 18F-DOPA -- 3. The lipogenesis pathway: radiolabeled Choline -- 4. 18F-FET -- 5. 18F-NaF -- 6. Somatostatin receptor analogs (68Ga-DOTATOC, 68Ga-DOTANOC, 68Ga-DOTATATE) -- 7. 7 64Cu-Radiopharmaceuticals -- 8. Amyloid Imaging -- 9. PET myocardial perfusion imaging: 82Rb -- 10. The Bone Pathway: 223Ra-Dichloride -- 11. 11C-Methionine -- 12. 68Ga-PSMA -- 13. PET biomarkers for Tau Pathology -- 14. 18F-Fluciclovine -- 15. 18F-FAPI -- 16. 18F-FES -- 17. 68Ga-Pentixafor -- 18. 18F-FLT -- 19. Neuroinflammation -- 20. 18F-FAZA.

The book is a practical and concise guide to PET tracers actually useful for PET/CT and PET/MR imaging. Gaining knowledge on radiopharmaceuticals is often difficult, since their features can be only found in single original journal articles.This book aims to present to the reader, in one single place, clinical features, indications and future trends for PET imaging with a large amount of tracers. While 18F-FDG still remains the miliar stone across PET tracer, new emerging fields of application of PET imaging are consolidated by using disease specific tracers in specific clinical settings. Each chapter is focused on a single tracer or on a group of similar tracers. The basis and structure of the chapters is the same throughout the book: essential information on synthesis and in vivo distribution of a tracer, clinical cases, eloquently showing clinical indications and usefulness, future trends, scientific literature. Featuring over 30 radiopharmaceuticals and 240 clinical cases, the 3rd edition has been enriched with additional chapters on the clinical indications and/or common pitfalls for 18F-fluciclovine PET/CT in prostate cancer imaging and for 18F-MISO in PET tumor hypoxia imaging, as well as applications and future directions for 18F-FES and other PET radiopharmaceuticals. All other chapters of the previous edition have been revised and updated, in particular those chapters covering 18F-DOPA, radiolabeled choline, and 18F-NAF, due to emerging clinical applications for these tracers, 18F-choline for imaging of parathyroid adenoma and 18F-DOPA for restaging of medullary thyroid cancer. The book will be an invaluable guide for professionals and residents in nuclear medicine, radiology, oncology.

ISBN: 9783031541964$q(electronic bk.)

Standard No.: 10.1007/978-3-031-54196-4doiSubjects--Topical Terms:

347769
Radiopharmaceuticals.

LC Class. No.: RM852 / .R33 2024

Dewey Class. No.: 616.07575

Radiopharmaceuticalsa guide to PET/CT and PET/MRI /
LDR:03341nmm a22003495a 4500 001 668220
003 DE-He213
005 20240830113252.0
006 m d
007 cr nn 008maaau
008 250107s2024 sz s 0 eng d
020 $a 9783031541964$q(electronic bk.)
020 $a 9783031541957$q(paper)
024 7 $a 10.1007/978-3-031-54196-4 $2 doi
035 $a 978-3-031-54196-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RM852 $b .R33 2024
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKR $2 thema
082 0 4 $a 616.07575 $2 23
090 $a RM852 $b .R129 2024
245 0 0 $a Radiopharmaceuticals $h [electronic resource] : $b a guide to PET/CT and PET/MRI / $c edited by Ferdinando Calabria, Orazio Schillaci.
250 $a Third edition.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a x, 330 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
347 $a text file $b PDF $2 rda
505 0 $a 1. 18F-FDG -- 2. 18F-DOPA -- 3. The lipogenesis pathway: radiolabeled Choline -- 4. 18F-FET -- 5. 18F-NaF -- 6. Somatostatin receptor analogs (68Ga-DOTATOC, 68Ga-DOTANOC, 68Ga-DOTATATE) -- 7. 7 64Cu-Radiopharmaceuticals -- 8. Amyloid Imaging -- 9. PET myocardial perfusion imaging: 82Rb -- 10. The Bone Pathway: 223Ra-Dichloride -- 11. 11C-Methionine -- 12. 68Ga-PSMA -- 13. PET biomarkers for Tau Pathology -- 14. 18F-Fluciclovine -- 15. 18F-FAPI -- 16. 18F-FES -- 17. 68Ga-Pentixafor -- 18. 18F-FLT -- 19. Neuroinflammation -- 20. 18F-FAZA.
520 $a The book is a practical and concise guide to PET tracers actually useful for PET/CT and PET/MR imaging. Gaining knowledge on radiopharmaceuticals is often difficult, since their features can be only found in single original journal articles.This book aims to present to the reader, in one single place, clinical features, indications and future trends for PET imaging with a large amount of tracers. While 18F-FDG still remains the miliar stone across PET tracer, new emerging fields of application of PET imaging are consolidated by using disease specific tracers in specific clinical settings. Each chapter is focused on a single tracer or on a group of similar tracers. The basis and structure of the chapters is the same throughout the book: essential information on synthesis and in vivo distribution of a tracer, clinical cases, eloquently showing clinical indications and usefulness, future trends, scientific literature. Featuring over 30 radiopharmaceuticals and 240 clinical cases, the 3rd edition has been enriched with additional chapters on the clinical indications and/or common pitfalls for 18F-fluciclovine PET/CT in prostate cancer imaging and for 18F-MISO in PET tumor hypoxia imaging, as well as applications and future directions for 18F-FES and other PET radiopharmaceuticals. All other chapters of the previous edition have been revised and updated, in particular those chapters covering 18F-DOPA, radiolabeled choline, and 18F-NAF, due to emerging clinical applications for these tracers, 18F-choline for imaging of parathyroid adenoma and 18F-DOPA for restaging of medullary thyroid cancer. The book will be an invaluable guide for professionals and residents in nuclear medicine, radiology, oncology.
650 0 $a Radiopharmaceuticals. $3 347769
650 0 $a Tomography, Emission. $3 276849
650 1 4 $a Nuclear Medicine. $3 275838
650 2 4 $a Radiology. $3 188995
650 2 4 $a Oncology. $3 195181
650 2 4 $a Urology. $3 318461
650 2 4 $a Hematology. $3 274899
650 2 4 $a Neurology. $3 211583
700 1 $a Calabria, Ferdinando. $3 865051
700 1 $a Schillaci, Orazio. $3 865052
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-54196-4
950 $a Medicine (SpringerNature-11650)